Navigation Links
NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program

BOSTON, July 8 /PRNewswire/ -- NorthPoint Domain, an IC Sciences company, announced today a collaboration with Boston Medical Center's (BMC) Cardiovascular Center to apply advanced Internet patient engagement "instruments" to BMC's cardiac robotic surgery program. Also known as "medical informatics instruments" (MIIs), these patient engagement tools are used by clinicians as informational and interactive tools that involve patients and their families in the care process. Built upon a web platform, informatics instruments represent a new way for clinicians to deliver medical care, making it feasible to educate and instruct patients and their families, set expectations, share decision-making, and support self-care in ways heretofore not possible.

The partnership unites the industry's most potent cardiovascular patient engagement instruments with one of the most innovative cardiac surgery programs in the country, and is an extension of the long-standing relationship between NorthPoint Domain and the BMC Cardiovascular Center. The organizations have collaborated since 2002 to use web-based MIIs to advance patient-centered care. NorthPoint Domain will work with the Cardiovascular Center to tailor its MII platforms, complementing the advanced robotic surgery technology currently being used at BMC. "NorthPoint Domain will greatly enhance our ability to inform and engage our patients and make them true partners in their own care," said Robert S. Poston, MD, Chief of Cardiac Surgery at BMC and Associate Professor of Cardiothoracic Surgery at Boston University School of Medicine.

Rony Sellam, President and Chief Operating Officer of NorthPoint Domain, added, "While BMC is among a handful of medical centers in the country offering minimally invasive robotic CABG, it will be the only center in the world combining this with our Internet instruments for informatics-powered care delivery."

Healthcare participants use MIIs developed and delivered by IC Sciences and NorthPoint Domain to provide a new generation of healthcare -- informed clinical care. This is patient-centered medicine enlightened and informed by MII-generated experience, evidence, prediction, and preference data. MIIs can provide potent functionality for partnering with and activating patients to participate in their care.

A burgeoning scientific evidence base, including a review of 24 randomized controlled trials, indicates that in chronic condition management patient engagement instruments achieve significant improvements not only in patient knowledge, care support, and behavioral outcomes, but also in clinical outcomes. (Murray et al) The partners expect to see similar benefits in the acute cardiac surgery care setting and are exploring future clinical studies to assemble an evidence base.


Murray E, et al. 2005. Interactive health communication applications for people with chronic disease. The Cochrane Database of Systematic Reviews Issue 4.

About IC Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit

About NorthPoint Domain, Inc.

NorthPoint Domain, Inc., a subsidiary of IC Sciences Corporation, provides care delivery informatics instruments for the specialty specific medical practice. These Internet-based instruments are designed to engage patients, consumers, and referring clinicians, address health literacy concerns, and deliver patient care oversight. Please visit for additional information.

About the Cardiovascular Center at Boston Medical Center

Boston Medical Center is the primary teaching affiliate of the Boston University School of Medicine. The Cardiovascular Center is a regional referral center that uses state-of-the-art technology to provide high-quality, cost-effective cardiac and vascular care. The BMC Cardiovascular Center is the only hospital in Boston -- and one of a handful in the United States -- to offer minimally invasive robotically assisted coronary artery bypass surgery. For more information about the BMC Cardiovascular Center, please visit

CONTACT: IC Sciences Corporation

One Joy Street Boston, MA 02108


SOURCE IC Sciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NorthPoint Domain and NYU Vascular Associates Partner to Develop New Generation of Care Delivery Informatics Instruments
2. Time Domain Showcases Precision Location Capability of Ultra Wideband PLUS Product Line at HIMSS 2008
3. TechCFO Adds Gary Strickland as Partner in Boston Office
4. Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
5. Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results
6. Boston Scientific Welcomes Revised Outlook From Fitch Ratings
7. Boston Scientific to Participate in Goldman Sachs Conference
8. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
9. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
10. Boston Scientific Completes Acquisition of CryoCor
11. Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells Group ... of a new closed system for isolating adipose-derived stem cells. The announcement starts a ... of adipose tissue. SVF is a component of the lipoaspirate obtained from liposuction of ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
(Date:11/30/2015)... 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the ... C.W. Wong to its Board of Directors to replace ... with a wealth of experience as co-founder of Resverlogix, with ... --> --> Dr. Wong remarked, ... of directors. Zenith,s long standing expertise in epigenetics and the ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... today that the company has acquired Cypher Genomics, Inc., ... and robust human genomic interpretation software solutions. The ... who will join HLI including Cypher CEO and Co-founder, ... head of HLI,s Pediatric Business.  Financial details of the ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):